Project Grant HT94252510242
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$200K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Evanston, IL 60208, USA
Similar Awards
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research investigating the development of nonmotor symptoms in Parkinson's disease. The $1,021,409 grant awarded to the University of Illinois will fund a 4-year study examining the role of maladaptive 5-HT raphe-corticolimbic plasticity in the progression of nonmotor symptoms in Parkinson's patients. The research aims to advance scientific...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
This federal Project Grant award of $494,774, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports the development of nonmotor biomarkers to diagnose Parkinson's disease subtypes at an early stage. The award recipient is Aarhus Universitet, a Danish state-controlled university, which will conduct this advanced biomedical research project from December 2024 to December 2026. As a specialized research...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
The Department of the Army Medical Command awarded a $400,000 Project Grant to Augusta University Research Institute, Inc. for research under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to May 30, 2024 to identify mechanisms and treatments for cognitive decline following neurotoxic alpha-synuclein exposure in new Parkinson's disease models. The Military Medical Research and Development program supports biomedical research with the goals...
This federal Project Grant award in the amount of $811,942 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the J. David Gladstone Institutes, a non-profit biomedical research organization, to investigate genetic factors conferring susceptibility to toxicant-induced Parkinson's disease. The research involves a sub-award to the Northern California Institute For Research And...
The U.S. Department of the Army Medical Command has awarded a $1,277,097 Project Grant to Oregon Health & Science University (OHSU) through the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "GLIMPSE-PD: GLYMPHATICS IMAGING TO PROBE SLEEP IN PARKINSON'S DISEASE," will support advanced biomedical research focused on transforming healthcare for military service members and the general public. The funding will enable OHSU researchers...
The Pennsylvania State University College of Medicine received a $1.29 million project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The four-year award will fund research into maladaptive nigrovagal pathophysiology in parkinsonism. Through September 2025, the university will investigate medical solutions for neurological conditions affecting service members and veterans, with the goal of transforming...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
This $1,480,186 Project Grant award from the Defense Health Agency supports research by Northeast Ohio Medical University (Neomed) to model cognitive dysfunction in Parkinson's disease and the impact of exercise. The research is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for service members and the public through innovative biomedical research, including solutions for the battlefield. As the sole awardee, Neomed...